Ever since its launch in 2009, BMJ Best Practice has been at the forefront of delivering high-quality evidence that informs clinical practice worldwide.
We achieve this through our rigorous and continuous evidence-based editorial processes, as well as the well-structured, consistent and intuitive way in which key evidence and relevant resources are displayed for instant use at the point of care.
BMJ Best Practice re-frames the research base into actionable advice. To allow decisions to be made on the best available evidence in a timely way we highlight evidence that is truly practice changing. This is based on awareness and knowledge of what needs to change, why and how.
BMJ Best Practice is the only clinical decision support tool that supports all three components of Evidence-Based Medicine:
- Best available evidence in the form of key primary and secondary studies and guidelines
- Clinical expertise via our 1,600 working clinical authors and editors from 29 countries
- Patient values and preferences with over 300 patient leaflets, accredited by the Information Standard and reviewed by the BMJ patient panel, to support shared decision making.
Our robust evidence processes include:
Evidence is evaluated daily and quickly incorporated into BMJ Best Practice content. Updates are prioritised as follows:
- Drug alerts/life threatening changes; within 24- 48 hours
- Evidence that changes practice; within one month
- Evidence that changes practice but not in acute topic; within one month
- Evidence that confirms current practice; within one month.